玻璃体切割手术联合全视网膜光凝术对糖尿病视网膜病变患者屈光状态及泪膜功能的影响

doi:10.3969/j.issn.1006-6233.2023.08.025

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1189 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the effect of vitrectomy combined with panretinal photocoagulation on refractive status and tear film function in patients with diabetes retinopathy. Methods: A total of 68 patients with diabetes retinopathy were selected. The standard three channel 23G vitrectomy combined with panretinal photocoagulation was used in the vitrectomy combined group, and the fundus laser therapeutic apparatus was used in the panretinal photocoagulation group. The efficacy was compared. Results: Before treatment, there was no significant difference in the best corrected visual acuity, tear film rupture time, and tear secretion test between the whole retina photocoagulation group and the glass cutting combined group (P>0.05). After 6 months of treatment, the glass cutting combined group had higher best corrected visual acuity, tear film rupture time, and tear secretion test than the whole retina photocoagulation group (P<0.05). The difference in tear film rupture time before and after treatment and the difference in tear secretion test before and after treatment in the combination group was higher than that in the whole retina photocoagulation group (P<0.05). Before treatment, there was no significant difference in refractive status and axial length between the whole retina photocoagulation group and the glass cutting combined group (P>0.05). The refractive status and axial length of the glass cutting combined group were higher than those of the whole retina photocoagulation group (P<0.05). Conclusion: Vitrectomy combined with panretinal photocoagulation is helpful to reduce the changes of refractive status and stabilize tear film function in patients with diabetes retinopathy.

Key words： Diabetes retinopathy Vitrectomy Panretinal photocoagulation Refractive state Tear film function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Wenbo
	JIA Xinguo
	WANG Qingqiang

Cite this article:

ZHANG Wenbo,JIA Xinguo,WANG Qingqiang. Effect of Vitrectomy Combined with Panretinal Photocoagulation on Refractive Status and Tear Film Function in Patients with Diabetes Retinopathy[J]. HeBei Med, 2023, 29(8): 1358-1362.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2023.08.025 OR http://www.hbyxzzs.cn/EN/Y2023/V29/I8/1358

[1] 万文萃,龙洋.糖尿病视网膜病变的流行病学、病因学与发病机制研究现状[J].眼科新进展,2022,42(9):673-679.
[2] 赖丽平,刘贺,黄锡岚,等.2型糖尿病患者的糖尿病视网膜病变患病率及危险因素[J].广西医学,2022,44(4):370-375.
[3] 张丽楠,宋其缘,窦晓燕.23 G微创玻璃体切割术联合雷珠单抗治疗增殖期糖尿病视网膜病变[J].中国现代手术学杂志,2021,25(5):380-384.
[4] 中华医学眼科学分会.糖尿病视网膜病变分期标准[J].中华眼科杂志,1985,21(2):113.
[5] 陈辑.全视网膜激光光凝术联合玻璃体腔内注射康柏西普对增生性糖尿病视网膜病变患者视功能恢复的影响[J].影像科学与光化学,2020,38(1):87-93.
[6] 温晏,王慧,于晓明,等.全视网膜光凝术对糖尿病视网膜病变患者视力的影响[J].河北医学,2017,23(9):1522-1524.
[7] 张楚,陈京霞,邹玉平.雷珠单抗联合全视网膜激光光凝术对糖尿病视网膜病变患者血清同型半胱氨酸、维生素B12、叶酸水平和视网膜动静脉循环时间的影响[J].中国医学前沿杂志(电子版),2019,11(11):102-105.
[8] 潘岳峰,张大卫,卢建民.全视网膜激光光凝术对糖尿病视网膜病变患者脉络膜厚度的影响[J].中国医刊,2022,57(3):305-308
[9] 司霞,孙楚枫,陈月,等.康柏西普辅助玻璃体切割术治疗增生性糖尿病视网膜病变的Meta分析[J].中华实验眼科杂志,2020,38(9):773-780.
[10] 代莉,李娟,邹明菊.增殖性糖尿病视网膜病变微创玻璃体切割术预后影响因素[J].安徽医药,2022,26(7):1433-1436.
[11] 吴林彬,周家承,谭荣强,等.微创玻璃体切割联合全视网膜光凝治疗糖尿病视网膜病变[J].国际眼科杂志,2014,14(4):760-762.
[12] 谢丽丽,刘颖,梁冬梅,等.非增殖期与增殖期糖尿病视网膜病变患者睑板腺功能比较研究[J].临床军医杂志,2022,50(9):978-979,982.